医渡科技(02158)公布，2026年2月3日耗资约821.79万港元回购146.28万股股份。 ...

如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 醫渡科技有限公司 呈交日期： 2026年2月3日 FF305 確認 根據《主板上市規則》第13.25C條 / 《GEM上市規則》第17.27C條，我們在此確認，據我們所知所信，第一章節所述的每項股份發行或庫存股份出售或轉讓已獲發行人董事會正式授權批准，並遵 照所有適用上市規則、法律及其他監管規定進行，並在適用的情況下： | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02158 | 說明 ...

责任编辑：王馨茹 2月3日金融一线消息，由新浪财经主办的"2025新浪金麒麟保险行业评选"结果今日正式揭晓！医渡云获 评"年度卓越惠民保科技服务商"。 2月3日金融一线消息，由新浪财经主办的"2025新浪金麒麟保险行业评选"结果今日正式揭晓！医渡云获 评"年度卓越惠民保科技服务商"。 责任编辑：王馨茹 ...

Group 1 - The core point of the news is that Yidu Tech (02158) has been actively repurchasing its shares, with a recent buyback of over 880,000 shares at approximately HKD 5.65 per share, totaling around HKD 5 million, marking a new high for single-day repurchase amounts [1] - The company has conducted share buybacks for six consecutive trading days, with a cumulative repurchase amount nearing HKD 15 million, indicating a strong commitment to its buyback plan and confidence in its intrinsic value and long-term growth prospects [1] - The ongoing buyback activity is supported by the steady progress of Yidu Tech's AI healthcare business and the enhancement of its core competitiveness, highlighted by a strategic partnership with Nanshan People's Hospital in Shenzhen to develop an "AI + health management" system [1] Group 2 - Recent business achievements include surpassing 4.5 million insured individuals in the 2026 Beijing Universal Health Insurance project, demonstrating the company's strong capabilities in the healthcare service sector [2] - The launch of the "General Medicine Diagnosis AI Assistant" in collaboration with Chongqing Medical University First Affiliated Hospital has been trialed in over 20 grassroots medical institutions in Chongqing, creating a replicable digital healthcare solution [2] - Industry experts view the company's share repurchase as a positive signal for investors, reflecting confidence in profitability growth and quality improvement, which can help maintain the company's value and enhance investor expectations for future development [2]

医渡科技(02158)发布公告，于2026年2月2日斥资499.84万港元回购88.54万股。 ...

智通财经APP讯，医渡科技(02158)发布公告，于2026年2月2日斥资499.84万港元回购88.54万股。 ...

格隆汇2月2日丨医渡科技(02158.HK)公告，2月2日耗资499.8万港元回购88.5万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 醫渡科技有限公司 呈交日期： 2026年2月2日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | | 事件 | 已發行股份（不包括庫存股 ...

Core Viewpoint - The company, Yidu Tech (02158), is actively repurchasing shares, signaling confidence in its long-term value while also making significant strides in business collaborations within the healthcare sector [1] Group 1: Share Repurchase - On January 30, Yidu Tech repurchased approximately 786,000 shares at around HKD 5.8 per share, costing over HKD 4.5 million [1] - The total amount spent on share repurchases over the past five days exceeds HKD 9.5 million, indicating a strong commitment to enhancing shareholder value [1] Group 2: Business Collaborations - Yidu Tech has established a strategic partnership with the Nanshan District People's Hospital in Shenzhen, launching the first domestic "AI + Health Management" innovative system that covers "full-time, full-domain, full-population, and full-cycle" [1] - This initiative aims to create a closed-loop AI medical ecosystem from research and development to application and transformation, marking a significant step in the implementation of smart healthcare solutions [1] Group 3: Market Developments - The company has reported that the number of participants in the 2026 "Beijing Universal Health Insurance" program has surpassed 4.5 million, showcasing its operational capabilities [1] - Additionally, Yidu Tech has collaborated with the First Affiliated Hospital of Chongqing Medical University to launch an "AI Assistant for General Medicine," further expanding its influence in the healthcare sector [1] - Market observers note that the combination of continuous share repurchases and multiple business collaborations highlights the company's dual strategy of "technological breakthroughs + scenario implementation," deepening its impact in the fields of medical intelligence and universal health [1]

Core Viewpoint - The company, Yidu Tech (02158), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Buyback Details - The company will repurchase 786,300 shares at a total cost of HKD 4.5579 million [1] - The buyback price per share ranges from HKD 5.72 to HKD 6.00 [1]